Sunshine Biopharma Statistics
Total Valuation
SBFM has a market cap or net worth of $7.51 million. The enterprise value is -$945,581.
Important Dates
The last earnings date was Wednesday, November 12, 2025, after market close.
| Earnings Date | Nov 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
SBFM has 4.91 million shares outstanding. The number of shares has increased by 867.50% in one year.
| Current Share Class | 4.91M |
| Shares Outstanding | 4.91M |
| Shares Change (YoY) | +867.50% |
| Shares Change (QoQ) | +3.46% |
| Owned by Insiders (%) | 0.04% |
| Owned by Institutions (%) | 11.08% |
| Float | 4.90M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 38.25 |
| PS Ratio | 0.14 |
| Forward PS | 0.32 |
| PB Ratio | 0.29 |
| P/TBV Ratio | 0.34 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.20, with a Debt / Equity ratio of 0.04.
| Current Ratio | 4.20 |
| Quick Ratio | 2.02 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -569.62 |
Financial Efficiency
Return on equity (ROE) is -24.34% and return on invested capital (ROIC) is -11.99%.
| Return on Equity (ROE) | -24.34% |
| Return on Assets (ROA) | -9.87% |
| Return on Invested Capital (ROIC) | -11.99% |
| Return on Capital Employed (ROCE) | -19.56% |
| Revenue Per Employee | $717,764 |
| Profits Per Employee | -$115,243 |
| Employee Count | 52 |
| Asset Turnover | 1.21 |
| Inventory Turnover | 2.09 |
Taxes
| Income Tax | -515,502 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -34.75% in the last 52 weeks. The beta is 0.73, so SBFM's price volatility has been lower than the market average.
| Beta (5Y) | 0.73 |
| 52-Week Price Change | -34.75% |
| 50-Day Moving Average | 1.67 |
| 200-Day Moving Average | 1.69 |
| Relative Strength Index (RSI) | 37.23 |
| Average Volume (20 Days) | 675,792 |
Short Selling Information
The latest short interest is 921,174, so 18.78% of the outstanding shares have been sold short.
| Short Interest | 921,174 |
| Short Previous Month | 364,928 |
| Short % of Shares Out | 18.78% |
| Short % of Float | 18.78% |
| Short Ratio (days to cover) | 0.50 |
Income Statement
In the last 12 months, SBFM had revenue of $37.32 million and -$5.99 million in losses. Loss per share was -$1.82.
| Revenue | 37.32M |
| Gross Profit | 12.32M |
| Operating Income | -4.86M |
| Pretax Income | -6.51M |
| Net Income | -5.99M |
| EBITDA | -4.56M |
| EBIT | -4.86M |
| Loss Per Share | -$1.82 |
Full Income StatementBalance Sheet
The company has $9.31 million in cash and $854,761 in debt, giving a net cash position of $8.45 million or $1.72 per share.
| Cash & Cash Equivalents | 9.31M |
| Total Debt | 854,761 |
| Net Cash | 8.45M |
| Net Cash Per Share | $1.72 |
| Equity (Book Value) | 24.20M |
| Book Value Per Share | 5.31 |
| Working Capital | 21.32M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$7.12 million and capital expenditures -$278,130, giving a free cash flow of -$7.40 million.
| Operating Cash Flow | -7.12M |
| Capital Expenditures | -278,130 |
| Free Cash Flow | -7.40M |
| FCF Per Share | -$1.51 |
Full Cash Flow StatementMargins
Gross margin is 33.01%, with operating and profit margins of -13.02% and -16.06%.
| Gross Margin | 33.01% |
| Operating Margin | -13.02% |
| Pretax Margin | -17.44% |
| Profit Margin | -16.06% |
| EBITDA Margin | -12.22% |
| EBIT Margin | -13.02% |
| FCF Margin | n/a |
Dividends & Yields
SBFM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -867.50% |
| Shareholder Yield | -867.50% |
| Earnings Yield | -79.84% |
| FCF Yield | -98.59% |
Analyst Forecast
The average price target for SBFM is $7.00, which is 357.52% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $7.00 |
| Price Target Difference | 357.52% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on August 8, 2024. It was a reverse split with a ratio of 1:20.
| Last Split Date | Aug 8, 2024 |
| Split Type | Reverse |
| Split Ratio | 1:20 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |
